Guidelines for the management of adult lower respiratory tract infections.
about
Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adultsChest radiographs for acute lower respiratory tract infectionsChest radiograph for acute respiratory infectionsAntibiotics for community acquired pneumonia in adult outpatientsEmpiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adultsPneumococcal vaccine in the elderly: a useful but forgotten vaccine.Antibiotic stewardship in the intensive care unit.Approaching the quality of antibiotic prescriptions in primary care using reimbursement data.Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.Appropriateness of antibiotic treatment in intravenous drug users, a retrospective analysisProcalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency departmentCausative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban populationEfficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia.Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort studyWhich patients with lower respiratory tract infections need inpatient treatment? Perceptions of physicians, nurses, patients and relativesImpact of macrolide therapy in patients hospitalized with Pseudomonas aeruginosa community-acquired pneumonia.An evaluation of prescribing practices for community-acquired pneumonia (CAP) in Mongolia.Health Economics of Antibiotics.Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosaDiagnostic value of triggering receptor expressed on myeloid cells-1 and C-reactive protein for patients with lung infiltrates: an observational study.Antimicrobial use and indication-based prescribing among general practitioners in Eastern Croatia: comparison with data from the European Surveillance of Antimicrobial Consumption project.Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.Severe pneumococcal pneumonia: impact of new quinolones on prognosis.Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm.A decision aid to rule out pneumonia and reduce unnecessary prescriptions of antibiotics in primary care patients with cough and fever.Mechanisms of action and clinical application of macrolides as immunomodulatory medications.Prediction of the pathogens that are the cause of pneumonia by the battlefield hypothesis.Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections.Community-acquired pneumonia in elderly patients.Socioeconomic determinants of outpatient antibiotic use in Europe.Clinical severity of rhinovirus/enterovirus compared to other respiratory viruses in childrenCritical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia.Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries.Standards of suitability for the management of chronic obstructive respiratory diseasesClinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and Slovakia.Intravenous moxifloxacin in routine hospital treatment of respiratory tract infections in China: results of a multicenter, noninterventional study.Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia.Hyponatremia and anti-diuretic hormone in Legionnaires' disease.
P2860
Q24200609-C0523A48-B5DD-4911-9E69-96038E144CFEQ24201603-A91A4636-A85E-4253-84B5-33D92067D800Q24234710-B8B9F4ED-7508-4CB5-BCBA-83CB800272EBQ24240033-C20364E2-D749-41A1-B28B-6A08373C9DA8Q24242728-592D5EF3-452C-481E-AAF9-7074FD62378EQ30378584-73F5341C-9F15-4324-B890-0E4B6BDB08E0Q30408712-57F90C94-BA1E-4CEF-AE80-A98792137503Q30566077-FF327EC0-992D-41ED-A760-BAD87F45EE64Q33290142-1C4B85C3-23DD-4EA1-94AA-F1184FBF52CDQ33326891-DE5D40E4-E571-4BF6-ABF9-1B200C800542Q33378956-1A2239ED-CC41-44A5-AE51-5EC4D1E68838Q33400876-2A0B4BD0-9452-497B-B5F5-61D2B46C36CEQ33418963-FB845720-DF0F-45D5-8125-D6ED2B8E24E0Q33501357-3904DE9C-5BAC-4D98-B9B9-F5972DC8C107Q33505806-63223EFE-D898-4EEB-8D96-846E1FB896B3Q33540012-7752BD0E-6489-406C-BDA5-451B286D4543Q33572569-0E48888F-B32F-4F27-925E-50771C5AC53AQ33592516-88A43EF7-3FD2-44CC-A68D-360EC534C608Q33664262-4FE859C5-661C-4130-89F1-6D0CA4ED5715Q33701145-2C53D34D-D6AD-4BD0-BEAF-036B3BD85888Q33709822-851621E9-1F29-493F-997E-D79611ACD5AAQ33772725-6F97DC48-9742-4F0B-8DA8-3E146A4C6D03Q33776590-34852BF8-998D-4A2D-B61E-35C93B753FA8Q33846631-81F429E8-BC05-4C04-A4C0-6039D8C7F2A0Q33888706-F0D0C847-9FB9-4494-9648-F6CDFB55077FQ33899010-5EB43EEE-080E-441C-94E9-1F377C988E25Q33983140-9E901233-2E32-4147-9263-4FA1282DB8EEQ34016665-032A1B38-F2B5-471E-908B-8C5B660E4078Q34026975-C4E7F373-9786-4F89-9E33-3BFE89F63254Q34048462-7FF80CE4-9269-4F81-A38D-C71FBAFDAB26Q34134859-94BAF34A-9DDD-48D7-991E-678B28CBE146Q34274830-B4E468C6-5013-493E-B0B7-E5B6B0360D3CQ34369912-D3565D83-6F56-44D4-9451-8CC4307D9175Q34550471-6010E206-BA6B-488D-A3D7-1148D70F99E3Q34609380-C1092F97-352E-4E81-91F1-40F4079AB12FQ34911219-9538F208-3795-40D0-A3C8-EB499C11E515Q34937466-DBB75FA3-7AD2-487E-A840-BB707F56E6E0Q35024966-BE570CF1-5E9A-4644-89C5-A3AAD88D795AQ35026616-74330047-C0D5-4B52-BA1D-B6B2FA2104E9Q35065229-B4AD54CB-0C51-456A-BDAD-7D02F406161B
P2860
Guidelines for the management of adult lower respiratory tract infections.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Guidelines for the management of adult lower respiratory tract infections.
@ast
Guidelines for the management of adult lower respiratory tract infections.
@en
Guidelines for the management of adult lower respiratory tract infections.
@nl
type
label
Guidelines for the management of adult lower respiratory tract infections.
@ast
Guidelines for the management of adult lower respiratory tract infections.
@en
Guidelines for the management of adult lower respiratory tract infections.
@nl
prefLabel
Guidelines for the management of adult lower respiratory tract infections.
@ast
Guidelines for the management of adult lower respiratory tract infections.
@en
Guidelines for the management of adult lower respiratory tract infections.
@nl
P2093
P1476
Guidelines for the management of adult lower respiratory tract infections.
@en
P2093
A Ortqvist
European Society of Clinical Microbiology and Infectious Diseases
G van der Heijden
M Woodhead
T J M Verheij
T Schaberg
P304
P356
10.1183/09031936.05.00055705
P577
2005-12-01T00:00:00Z